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ABSTRACT
Pharmaceutically active compounds (PhACs) have recently
received wide attention in the scientific community due to
their extensive consumption for human health and conse-
quent discharge to the environment. Release of PhACs into
the environment, even in trace amounts, can cause serious
environmental damage. This has become a major concern
and their removal from water sources is a priority. Although a
few PhACs are efficiently removed in wastewater treatment
plants (WWTPs), others remain recalcitrant, and their release
is causing damage. In this review, the current state of the art
on the biological removal processes of sulfonamide sulfa-
methoxazole (SMX), the anticonvulsant carbamazepine (CBZ),
and steroid estrogens 17b-estradiol (E2) and 17a-ethinylestra-
diol (EE2) are discussed, along with their environmental
impact. Other systems beyond activated sludge, such as
membrane bioreactors, enzymatic membrane reactors, fungi
treatments and hybrid systems are also becoming of major
interest and are being evaluated for the removal of these
compounds. Future perspectives are addressed.
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1. Introduction
PhACs are an emerging concern worldwide. The European Union (EU) is
the second biggest consumer in the World, with 24% of the total consump-
tion, just a little less than the United States of America. Consumption per
capita in EU ranges from 50 to 150 g year1 for human medical products
(Mugdal et al., 2013). About 4000 PhACs are used around the World for
many purposes, with production rates reaching up to 100,000 tons year1
for a number of them (IWW, 2014).
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Regarding the particular case of the anticonvulsant, carbamazepine (CBZ),
the world’s annual consumption is estimated at 1,014 tons (Zhang, Geißen, &
Gal, 2008). With respect to the total amount of discharged natural steroid
estrogens (estrone – E1, estriol – E2 and 17b-estradiol – E3), it is estimated in
29.5 tons year1 (considering the world’s population of 6.7 billion inhabitants).
Moreover, 720 kg year1 of synthetic estrogens (17a-ethinylestradiol – EE2)
are also released solely by contraceptive pills used (Combalbert & Hernandez-
Raquet, 2010). Antibiotics consumption increased 65% between 2000 and
2015, from 21.1 to 34.8 billion daily doses (DDDs) and the consumption rate
also increased 39% (from 11.3 to 13.7 DDDs inhabitant1day1; Klein et al.,
2018). The total amount of antibiotics is estimated between 100,000 and
200,000 ton year1 with approximatively 50% used for veterinary medicine and
as growth promoters (K€ummerer, 2003; Danner, Robertson, Behrends, & Reiss,
2019), sulfonamides being one of the most commonly used for veterinary pur-
poses (Sarmah, Meyer, & Boxall, 2006a).
1.1. PhACs in wastewaters
PhACs are commonly present in domestic sewages largely because of
human excretion. Indeed, some of these compounds are not completely
metabolized during their therapeutic use and are excreted unchanged
(Mohapatra, Brar, Tyagi, Picard, & Surampalli, 2014). PhACs are nowadays
considered as an emerging environmental problem due to their continuous
release into and persistence in the aquatic ecosystem, even at low concentra-
tions (Carabin, Drogui, & Robert, 2015). Concern about this release in recent
decades is growing; the extent of their effects remains relatively unknown,
due to lack of standard methods of quantification. This is considered a major
challenge in water resources management (Geissen et al., 2015).
The interest of studying PhACs in full-scale wastewater treatment plants
(WWTPs) has been increasing over the last decades, mainly due to the
large amounts of PhACs that can be present. Although some of these com-
pounds can mostly be removed, a few cannot, causing a number of serious
environmental and human health problems due to their recalcitrance. In
this sense, sulfonamide antibiotics, anticonvulsants, and steroid estrogens
are 3 major PhACs classes of particular interest and concern due to their
extensive use in human health.
1.2. PhACs metabolism in the human body
The most common antibiotics found in WWTPs cover a wide range of
classes, such as b-lactams, quinolones, lincosamides, macrolides, tetracyclines,
polyether ionophores, polypeptides, sulfonamides and others (Watkinson,
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Murby, & Costanzo, 2007). The sulfonamide sulfamethoxazole (SMX) is
widely applied as a broad-spectrum bacteriostatic drug because it interferes
with folic acid synthesis in susceptible bacteria. SMX is used all over the
world for the treatment of bronchitis, prostatitis and urinary tract infections
(Lipman, 1993; Cavallucci, 2007). It should also be stressed that SMX is usu-
ally used in combination with trimethoprim for increased reduction of tetra-
hydrofolic acid synthesis (Drugbank, 2016b). The mechanism of action of
SMX involves the inhibition of the bacterial synthesis of dihydrofolic acid,
thus decreasing the synthesis of bacterial nucleotides and DNA. It inhibits
the enzymatic conversion of pteridine and p-aminobenzoic acid (PABA) to
dihydropteroic acid by competing with PABA for binding to dihydrofolate
synthetase. As a result, it inhibits the tetrahydrofolic acid synthesis required
for purines and deoxythymidine monophosphate (dTMP) synthesis, thus
affecting bacterial growth.
The metabolism of SMX in the human body is largely hepatic and occurs
predominately by N4-acetylation (N4-acetyl-SMX), although glucorination
(SMX-N1-Glu, SMX-2-Glu) also occurs (Drugbank, 2016b). Significant
amounts (45–75%) of ingested sulfonamides are excreted by the human
body within 24 h, thus entering WWTPs through the sewage systems and
being found in surface waters (Calamari, Zuccato, Castiglioni, Bagnati, &
Fanelli, 2003; Radke, Lauwigi, Heinkele, M€uRdter, & Letzel, 2009).
Regarding the specific case of SMX, it should be stressed also that 15 to
30% is excreted unaltered from humans (Hirsch, Ternes, Haberer, & Kratz,
1999, RxList, 2016b).
Anticonvulsants are a class of PhACs that act by reducing abnormal
activity in the brain, and are applied in the treatment of mental illnesses,
depression, post-traumatic stress disorders, and drug and alcohol depend-
encies, among others (Mohapatra et al., 2014). One of the most frequently
detected anticonvulsant in water bodies is carbamazepine (CBZ) (Zhang
et al., 2008), usually employed in the treatment of epilepsy, seizures, trige-
minal neuralgia, diabetic neuropathy, bipolar disorder, and drug and alco-
hol dependencies, among others (RxList, 2016a; Drugbank, 2016a). The
mechanism of action of CBZ involves inhibiting sustained repetitive firing
by blocking use-dependent sodium channels, norepinephrine release, synap-
tic transmission in the trigeminal nucleus, and reduction of post-tetanic
potentiation on the spinal cord synaptic transmission. It is also believed to
possess anticholinergic, antidiuretic, antiarrhythmic, and antidepressant
activity, thus acting as a muscle relaxant and sedative (Drugbank, 2016a).
The metabolism of CBZ in the human body leads to the formation of
10,11-epoxycarbamazepine (EP-CBZ) and 10,11-dihydro-10,11-trans-dihy-
droxycarbamazepine (DiOH-CBZ). The CBZ is transformed by the cyto-
chrome P450 3A4 (CYP3A4) in the liver and possibly undergoes
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glucuronidation by UDP-glucuronosyltransferase-2B7 (UGT2B7) isoen-
zyme. Only 3% of CBZ remains unchanged when excreted, and is mainly
found in the urine, whereas their (mono)hydroxylated and conjugated
metabolites can be found in the feces (RxList, 2016a; INCHEM, 2016;
Toxnet, 2016).
Steroid hormones are a group of biologically active compounds synthe-
sized from cholesterol and with a common cyclopentane-perhydro phenan-
threne ring (Ying, Kookana, & Ru, 2002). Four of the estrogens most
commonly found in wastewater include 3 natural steroids (17b-estradiol
(E2), estrone (E1) and estriol (E3)) and one synthetic compound (17a-ethi-
nylestradiol (EE2)) (Racz & Goel, 2010). E2 is a naturally occurring steroid
hormone, being the major female sex hormone, and is essential factor in
the regulation of the menstrual cycle, in the development of puberty and in
secondary female sex characteristics. E2 can also be present in hormone
therapy products, such as reduced estrogen production (menopausal and
peri-menopausal symptoms), treatment of hypoestrogenism, palliative treat-
ment of breast and prostate cancer, as well as for transgender hormone
therapy (Drugbank, 2016c). EE2 is used mainly for the treatment of vaso-
motor symptoms associated with the menopause, female hypogonadism,
prostatic carcinoma-palliative therapy, treatment of breast cancer, and
contraceptive purposes (Drugbank, 2016d).
The mechanism of action of estrogens is based on the interaction with a
protein receptor on the cells of the female reproductive tract, mammary
glands, hypothalamus and pituitary gland. This leads to an increased syn-
thesis of sex hormones binding globulins in the liver, thyroid-binding glob-
ulins and serum proteins, as well as the suppression of the follicle-
stimulating hormone. Metabolism of estrogens in the human body is
largely hepatic, mainly by aromatic hydroxylation (for both synthetic and
natural estrogens); for instance, E2 is excreted in the urine along with glu-
curonide and sulfate conjugates. While glucuronide conjugates can be
mostly removed, or transformed back to the original compounds, sulfate
conjugates are likely found in treated wastewaters due their lower deconju-
gation rates.
With respect to the toxicity of E2 conjugates, more studies are needed to
confirm the effect of these compounds in aquatic organisms (Drugbank,
2016c; Liu, Lu, Yin, Dang, & Rittmann, 2015, Zhang, Zhao, & Fent, 2017).
E2 is one of 3 naturally occurring steroid estrogens produced by the human
body. Females excrete on average more E2 than males (2.9 and 1.6 lg
day1, respectively), with menstruating (3.5 lg day1) and pregnant (259 lg
day1) women excreting particularly large amounts of this natural estro-
genic compound (Johnson, Belfroid, & Di Corcia, 2000; Wise, O’Brien, &
Woodruff, 2011). Regarding EE2, the main metabolite is 2-hydroxy-
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ethinylestradiol, but a number of other hydroxylated and methoxylated
metabolites can also be found in the free form or as sulfates and conju-
gated glucuronides (Drugbank, 2016d). The major source of EE2 excretion
is urine, in contrast with feces where large E. coli populations are able to
deconjugate EE2 metabolites due to their b-glucuronidase and sulfatase
activities (Dray, Dray, & Ullmann, 1972; Desbrow, Routledge, Brighty,
Sumpter, & Waldock, 1998).
This review outlines the importance, strategies, and efficiency of the
removal processes of the sulfonamide SMX, the anticonvulsant CBZ, and
the estrogens E2 and EE2 in biological wastewater treatment (WWT) sys-
tems. With the concerns discussed above, accordingly SMX, CBZ, E2 and
EE2 have in particular been addressed in this review, covering the main
sources of these PhACs, and their impacts in soils, surface waters, aquatic
biota and human health. Furthermore, the impact of PhACs on microbial
communities in the WWTPs is far from negligible and, for that reason, this
topic will be also discussed.
Several studies have already shown that conventional activated sludge
(CAS) treatment in WWTPs is inefficient for the removal of a large number
of PhACs (Hirsch et al., 1999; Joss et al. 2006). Based on this information,
different technologies have been studied and applied to obtain a sustainable
removal of PhACs, including membrane reactors (MBR), enzymatic mem-
brane reactors (EMR) and hybrid systems (HS), among others (Salgado
et al., 2012; Mohapatra et al., 2014; Petrie, Barden, & Kasprzyk-Hordern.,
2015; Grandclement et al., 2017; Tiwari et al., 2017; Besha et al., 2017;
Ahmed et al., 2017). Although knowledge of the relationship between the
WWTPs operational conditions and the removal efficiencies of PhACs
has been increasing, further information on the cost-benefit aspects of these
technologies are of major interest to achieve full-scale implementation.
Therefore, we will also be discussed herein the future perspectives and chal-
lenges regarding the sustainable removal of these compounds.
2. Sources and environmental impact assessment of PhACs
SMX, CBZ, E2 and EE2 can flow into WWTPs from hospital activities,
clinical analysis laboratories and industrial activities such as pills produc-
tion in the pharmaceutical industry (Cui, Ji, & Ren, 2006; Avbersek,
S€omen, & Heath, 2011; Zhou, Zha, Xu, Lei, & Wang, 2012). Moreover, the
surface waters distributed to the urban environment, even when treated in
water treatment plants (WTP), may contain considerable amounts of these
PhACs (Ting & Praveena, 2017), which later contaminate soils and aqui-
fers. Figure 1 shows the main sources of SMX, CBZ, E2 and EE2 flowing
into a WWTP, as well as the dissemination of these compounds in different
702 C. S. LEAL ET AL.
environmental compartments, including water, wastewater, soils and
aquatic biota.
PhACs are been commonly found in ground waters, surface waters,
treated wastewaters, and even drinking waters, in concentrations up to tens
of nanograms per liter for E2, hundreds of nanograms per liter regarding
SMX, up to 1mg L1 for EE2, and even >1mg L1 for CBZ. The concen-
trations SMX, CBZ, E2 and EE2 in aquatic systems reported by others are
given in Table 1. Furthermore, a wide variety of PhAC conjugated metabo-
lites may undergo deconjugation in the environment, being transformed
back to their original forms (Celiz, Tso, & Aga, 2009).
The ecotoxicity of PhACs is usually assessed by means of the Lowest
Observed Effect Concentration (LOEC) and Predicted No-Effect
Concentration (PNEC). Table 2 gives further information about the PNEC
and the LOEC for the toxicity assessment of SMX, CBZ, E2 and EE2. CBZ
had LOEC values ranging from hundreds of micrograms per liter in arthro-
pods and rotifers and up to tens of milligrams per liter in fish (Ferrari,
Paxeus, Lo Giudice, Pollio, & Garric, 2003). With respect to the PNEC, val-
ues as low as a few nanograms per liter for E2 (Anderson et al., 2012), and
even lower for EE2 (Laurenson, Bloom, Page, & Sadrieh, 2014), were found
in aquatic life. Ma and Yates (2018) found that 17ß-estradiol-3-sulfate (E2-
3S) conjugate is more persistent in rivers and streams than 17ß-estradiol-3-
glucuronide (E2-3G) conjugate. However, since the ecotoxicity of these
Figure 1. SMX, CBZ, E2 and EE2 in different environmental compartments (Ting & Praveena, 2017).
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Table 1. Concentrations of SMX, CBZ, E2 and EE2 in aquatic systems.
Compound Concentration Type of water References
SMX Around 410 ng L1 Ground water Sacher, Lange, Brauch,
and Blankenhorn (2001)
Around 480 ng L1 Surface water Hirsch et al. (1999)
Around 66 ng L1 Drinking water M€uckter (2006)
CBZ 390 ng L1 (max) Ground water Loos et al. (2010)
Above 1 mg L1
0.060 mg L1
1075 ng L1
0.650 ng L1(max)
Surface water Wiegel et al. (2004)
Thill (2005)
Heberer et al. (2002)
Metcalfe et al. (2003b)
30 ng L1 Drinking water Ternes (1998)
6.3mg L1 WWTPs effluents Ternes (1998)
2.3 mg L1(max) Discharged wastewater Metcalfe et al. (2003)
E2 1 to 22 ng L1 WWTPs Pal, Gin, Lin, and Reinhard (2010)
0 to 4.5 ng L1 River streams Pal et al. (2010)
EE2 0 to 9 mg L1 Treated wastewater Baronti et al. (2000)
831 mg L1 (max.) and
73 mg L1 (avg.)
Stream water Kolpin et al. (2002)
Table 2. PNEC and LOEC regarding SMX, CBZ, E2, and EE2 toxicity assessment.
Compound LOEC PNEC References
SMX n.a
n.a
0.59 mg L1 for aquatic life
0.89 mg L1 for aquatic life
Straub (2016)
Huang et al. (2018)
1.97 nmol L1 for river
biofilms communities
n.a Yergeau, Lawrence, Waiser,
Korber, and Greer (2010);
Yergeau et al. (2012)
Avetyl-SMX n.a 28 ng L1 for Vidu bay
in lake Geneva
Bonvin, Chevre, Rutler,
and Kohn (2012)
SMX-Glu n.a 28 ng L1 for Vidu bay
in lake Geneva
Bonvin et al. (2012)
CBZ 100 mg L1, 754 mg L1
and 50mg L1 for
C. dubia, B. calyciflorus and
D. rerio respectively
n.a Ferrari et al. (2003)
n.a 6.359 mg L1 for daphnids Jones, Voulvoulis,
and Lester (2002)
EP-CBZ n.a 2500 ng L1 for Vidu bay
in lake Geneva
Bonvin et al. (2012)
DiOH-CBZ n.a 2500 ng L1 for Vidu bay
in lake Geneva
Bonvin et al. (2012)
Acridone 1.44–3.07mg L1 and
1.09mg L1 for V. fischeri
and P. subcapitata
respectively
n.a Donner et al. (2013)
E2 n.a 5 ng L1 (short term on fish) Anderson et al. (2012)
n.a 2 ng L1 (long term on fish) Anderson et al. (2012)
Below 8.94 ng L1, below
28.8 ng L1 and below
85.9 ng L1 for medaka,
fathead minnow, and
zebrafish respectively
n.a Seki, Fujishima, Nozaka,
Maeda, and Kobayashi (2006)
n.a 2 ng L1 Caldwell, Mastrocco, Anderson,
Lange, and Sumpter (2012)
EE2 n.a 0.1 ng L1 for aquatic life Pawlowski, Van Aerle, Tyler,
and Braunbeck (2004);
Laurenson et al. (2014)
1 ng L1 for fathead minnow n.a Pawlowski et al. (2004)
n.a – Not available
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compounds remains unknown, further studies are needed. SMX also has
low PNEC values, <1 microgram per liter, for aquatic life (Straub, 2016).
However, the toxicity values of PhACs reported in the literature should be
carefully analyzed since the results are strongly dependent on the species
involved, and whether in vitro or in vivo assays are used (Laurenson
et al., 2014).
2.1. Sulfonamides
Sulfonamides, including SMX, are widely prescribed and used to treat ani-
mals and humans all over the world with its acetylated and conjugated
compounds posing an environmental risk (Hruska & Franek, 2012).
Although Andreozzi, Raffaele, and Nicklas (2003) report that direct and
indirect photodegradation can be an important process for the elimination
of SMX, these compounds are only partially degraded in the environment;
as a result, they are likely to accumulate in water bodies such as ground
waters, surface waters and drinking waters in amounts up to hundreds of
nanograms per liter (Table 1). On the other hand, acetylsulfamethoxazole,
a SMX metabolite that may be transformed back to the parent form, has
been detected at concentrations approaching 100 ng L1 in WWTPs efflu-
ents and river streams (G€obel, McArdell, Suter, & Giger, 2004; Ashton,
Hilton, & Thomas, 2004). Moreover, the concentrations of these antibiotics
in WWTPs varies according to the consumption patterns, as well as the
treatment methodology (Michael et al., 2013).
The effects of SMX in aquatic life remains poorly understood, and lacks
information of the potential consequences of this antibiotic in the environ-
ment due to waste water discharge or reuse (Watkinson et al., 2007). Lin,
Chen, and Chen (2013) showed the toxic effects of sulfonamides (including
SMX), even at low concentrations, on the spontaneous movements, heart-
beats and malfunctions of zebra fish embryos and larvae. SMX exposure
can also lead to changes on the zebra fish liver (Madureira et al., 2012).
Exposure of zebra fish to sulfonamides (including SMX) has also been
related to pericardial edema, York sac edema hemagglutination, tail
deformation and swim-bladder defects (Lin et al., 2013). SMX and SMX-
transformation products (SMX-TP) resulting from the SMX biodegradation,
photolysis or hydrolysis in the aquatic environment can also have acute
effects on Vibrio fischeri, leading to inhibition of luminescence. However,
the effects of SMX-TP seem to be lower than their parent compound
(Majewsky et al., 2014). On the other hand, Osorio et al. (2016) showed
that SMX had no individual acute toxicity on V. fischeri and Daphnia
magna (using standardized acute toxicity tests), although synergic effects
were determined with Diclofenac and nitro Diclofenac derivatives. However,
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the mechanism behind these effects is poorly understood. Bisphenol A,
humic acid and E2 also have a synergistic interaction with SMX leading to
an increase of estrogenicity in water bodies by up to 5-fold (Ali, 2014).
The long-term persistence of antibiotics (at low concentrations) in the
environment can promote the proliferation of antibiotic resistant bacteria
in river streams and, thus stimulate microorganism drug resistance
(Martinez, 2008; Watkinson, Murby, Kolpin, & Costanzo, 2009). Detection
of sulfonamide resistance genes in river microorganisms and aquatic bio-
film communities (Luo et al., 2010; Koczura, Mokracka, Taraszewska, &
Łopacinska, 2016; Aubertheau et al., 2017), alongside the prevalence of
SMX-resistant bacteria in aquaculture environments (Gao et al., 2012),
have been correlated to the total SMX concentration, among other sulfona-
mides, in those environments. On the other hand, some investigations have
shown that the bacterial resistance develops more slowly when trimetho-
prim and sulfamethoxazole are combined rather than when they are used
alone (Drugbank, 2016b; Vilcheze & Jacobs, 2012). The fact that TMP and
SMX target successive steps of the folate biosynthesis pathway can be the
reason for this behavior. Whereas SMX inhibits dihydropteroate synthase
TMP targets dihydrofolate reductase in the bacterial de novo folate synthe-
sis pathway (Vilcheze & Jacobs, 2012).
Besides their impact in aquatic biota, SMX, among others sulfonamides,
were also found in soil (Wang et al., 2015), with their sorption behavior
being related to soil properties, such as the presence of manure or organic
carbon source, and to the pH. In agricultural runoff waters resulting from
biosolids introduction in soils, SMX deconjugation can also lead to
increased concentrations of the SMX parent form with time (Topp et al.,
2008). Another important issue that is closely related to the presence of
SMX in soils is the effect of this compound in their microbial community.
In this sense, Demoling, Bååth, Greve, Wouterse, and Schmitt (2009)
showed that SMX initially decreased growth rates of sensitive bacterial spe-
cies in the soil (assessed by leucine incorporation). SMX showed also an
apparent correlation with the soil microbial diversity, measured by the
Shannon-Winner index, the Pielou’s evenness index and Simpson’s index
of diversity (Wang et al., 2016). Simpson’s index of diversity indicates the
probability of 2 individuals from an infinitely large community belonging
to the same species, with higher values showing the predominance of fewer
species, and consequently lower biodiversity. The Shannon-Winner index
increases with biodiversity, attributing a higher importance to rare than to
common species (Magurran, 2004).
Different SMX effects in soil-plant systems have already been detected,
for instance their higher rate accumulation in radish than in packoi cul-
tures, and an apparent correlation with seed germination and up-ground
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plant growth (Wang et al., 2016). According to Liu et al. (2009), root
elongation was sensitive to SMX (and sulfamethazine) during plant germin-
ation and growth. These antibiotics also inhibited soil phosphatase activity,
as well as affecting temporal changes on soil respiration. However, these
authors also considered that the expected effects regarding plant growth
and soil microbial activities may be mild, and show a quick recovery due
to loss and/or binding of SMX on to soil components. On the other hand,
Brain, Ramirez, Fulton, Chambliss, and Brooks (2008) showed that SMX
could disrupt the synthesis of folate and the substrate of dihydropteroate
synthase in Lemma giba, using p-aminobenzoic acid as a biomarker. Due
to its properties, SMX dissolves in cell membranes and is released into the
cytosol in plants (Goldstein, Shenker, & Chefetz, 2014). More recently,
Christou et al. (2019) has proved that tomatoes can uptake and accumulate
SMX in hydroponic conditions, increasing their carbohydrate content.
However, different results were obtained by Wu, Conkle, Ernst, and Gan
(2014), who did not detect SMX in plant tissues, or in fields irrigated with
treated wastewater. Despite the amount of information in the literature,
further research is needed to address the effects of SMX in plants.
Regarding human health as a result of chronic exposure to environmen-
tal antibiotics, Hamscher, Pawelzick, Sczesny, Nau, and Hartung (2003)
have stresed that a large number of antibiotics can give rise to allergic risks.
Indeed, with respect to sulfonamides, a number of investigations have
reported these allergic effects of sulfamethazine (Hjorth & Roed-Petersen,
1980; Choquet-Kastylevsky, Vial, & Descotes, 2002). Although no SMX
effects alone have been thoroughly reported, Pomati et al. (2006) refer to
the inhibition of human embryonic kidney cells at concentrations of nano-
grams per liter for a mixture of antibiotics containing sulfamethoxazole.
On the other hand, Straub (2016) stated that no risk is apparent for indir-
ect human exposure to SMX through drinking water and food, whereas
Uslu, Jasim, Arvai, Bewtra, and Biswas (2013) came to the same conclusion
regarding water bodies. However, this is not the case for sulfamethazine,
which has the potential to increase thyroid gland follicular adenoma
(Leung et al., 2013).
2.2. Anticonvulsants
As already mentioned, CBZ is widely applied as an anticonvulsant in epi-
lepsy and in the treatment of drug and alcohol dependencies, among others
applications. In the environment, CBZ can undergo a slow process of pho-
todegradation (estimated half-life 100 days) in waters free of salt and
organic compounds (Andreozzi et al., 2003). In WWTPs, the photolysis
step of UV treatment can also lead to a mixture of different carbamazepine
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transformation products, such as acridine and acridone (Donner et al.,
2013); however, biotransformation has been recognized as the main elimin-
ation mechanism of CBZ, though retransformation from its conjugated
metabolites can impair this process (Polesel, Andersen, Trapp, &
Plosz, 2016).
Several studies have shown that conventional biological WWT systems
are ineffective in removing CBZ (Bahlmann, Weller, Panne, & Schneider,
2009; Bahlmann, Brack, Schneider, & Krauss, 2014; Kruglova et al., 2014);
for this reason, CBZ is the most common PhAC found in aquatic systems,
including surface and ground waters (Clara, Strenn, & Kreuzinger, 2004)
(Table 1). In fact, according to Ternes (1998) and Heberer, Reddersen, and
Mechlinski (2002), CBZ has been detected at up to 6.3mg L1 in WWTPs
effluents (Ternes, 1998), above 1 mg L1 in surface waters (Wiegel et al.,
2004), up to 390 ng L1 in ground waters (Loos et al., 2010) and up to
30 ng L1 in drinking waters (Ternes, 1998). On the other hand, metabo-
lites such as EP-CBZ, carbamazepine-10,11-dihydrodiol, 2-hydroxycarbama-
zepine and 3-hydroxycarbamazepine can be present in concentrations
exceeding 1 mg L1 in treated wastewaters, and up to 2 ng L1 in surface
waters (Miao & Metcalfe, 2003).
CBZ can be potentially harmful, even toxic, to aquatic life at concentra-
tions below 100mg L1. However, toxicity levels are quite dependent on
the test organisms (Fent, Weston, & Caminada, 2006). Assessment of the
ecotoxicological impact of CBZ in aquatic biota showed decreases in D.
magna mobility and V. fischeri bioluminescence (Jos et al., 2003).
Moreover, Allium cepa and Chlorella vulgaris have been affected by CBZ
exposure (at up to 1000 mmol L1 of CBZ), with their growth decreasing
with contact time and CBZ concentration (Jos et al., 2003). Similar results
have also been found by others regarding the CBZ toxic effect in fish liver
tissue (Madureira et al., 2012) and in embryos. van den Brandhof and
Montforts (2010) showed a clear negative effect on Danio rerio growth at
concentrations >30.6mg L1.
Regarding the ecotoxicity of CBZ’s main metabolites, EP-CBZ was sig-
nificantly more toxic (LC50 of 0.20mg Kg
1) to Chironomus riparius than
CBZ (LC50 of 1.20mg Kg
1), assessed by the 40-day sediment full life-cycle
test. With respect to the EP-CBZ metabolite and its transformation prod-
ucts, fetal malformations in mice have also been described (Bennett et al.,
1996). In addition, the decrease of V. fischeri bioluminescence, the inhib-
ition of Pseudokirchneriella subcapitata growth and the decrease of D.
magna mobility have also been reported for acridine and acridone, result-
ing from the photolysis step of UV treatment (Donner et al., 2013). On the
contrary, no toxic effects have been reported so far for DiOH-CBZ (Heye
et al., 2016).
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Bioassays of ecotoxicity have also run on bacteria, algae, microcrustaceans
and fish to estimate their PNEC and assess risk. Ferrari et al., (2003) concluded
that CBZ seems to be more hazardous than the other PhACs, which is further
emphasized considering that CBZ was the sole PhAC appearing in all of the
WWTPs that were examined.
Regarding chronic effects, most of the data so far refers to those of CBZ
on the hormonal and nervous systems in lower vertebrates and inverte-
brates (Ferrari et al., 2003; Thill, 2005). Others have shown that chronic
effects (lasting over generations), as well as synergic effects with other
chemicals, cannot be excluded (Jos et al., 2003; Lamichhane, Garcia,
Huggett, Deangelis, & La Point, 2013). In fact, Ferrari et al. (2003) deter-
mined a LOEC of 100 mg L1 for Ceriodaphnia dubia, 754 mg L1 for
Brachionus calyciflorus and 50mg L1 for D. rerio. Indeed, WWTPs dis-
charges containing CBZ can have a profound effect on aquatic biofilms
communities through fixation of this compound (Aubertheau et al., 2017).
Furthermore, several effects can occur (even over generations) when CBZ
is released into the environment, including fixation in sediments and pro-
found effects in insects (such as Chironomids) affecting food webs. In this
sense, life-cycle tests are quite fundamental in minimizing CBZ risks to the
environment (Nentwig, Oetken, & Oehlmann, 2004).
CBZ is also one of the most studied PhACs in soils, with many
researches trying to understand its behavior (including the interactions
with organic materials) in several types of soils (Stein, Ramil, Fink, Sander,
& Ternes, 2008; Navon, Hernandez-Ruiz, Chorover, & Chefetz, 2011; Fenet
et al., 2012; Foolad, Hu, Tran, & Ong, 2016; Paz et al., 2016). CBZ has a
lower sorption affinity and a higher diffusion in soils compared to the par-
ent compounds, EP-CBZ and DiOH-CBZ, and it can be easily transported
from soil surfaces to aquifers (Paz et al., 2016). In fact, similar results were
obtained when treated wastewater was used for the irrigation of soils and
recharging of artificial aquifers (Fenet et al., 2012).
Regarding the effect of the chronic exposure to CBZ in water and food
products on the human health, Uslu et al. (2013), among others, have sug-
gested no apparent risks regarding the concentrations of CBZ found in
these sources. On the other hand, the 2-hydroxycarbamazepine metabolite
may lead to the formation of 2-hydroxyiminostilbene, and later to imino-
quinone, which, ultimately, can be responsible for carbamazepine-mediated
adverse drug reactions in humans (Ju & Uetrecht, 1999).
2.3. Steroid estrogens
Estrogens present in the environment in concentrations up to hundreds of
micrograms per liter can have a large impact on human and animal health
CRITICAL REVIEWS IN ENVIRONMENTAL SCIENCE AND TECHNOLOGY 709
(Stumpe & Marschner, 2007). Since human excretion is a major source of
the estrogens found in domestic wastewaters, the amount of estrogens, and
namely EE2, depends of several factors, including gender, hormonal and men-
strual state, pregnancy and contraceptive use (Johnson & Sumpter, 2001).
WWTPs effluents could be seen as one of the major sources of E2 and
EE2 in surface and ground waters (Table 1) due to its inefficient removal
(Braga, Smythe, Sch€afer, & Feitz, 2005), alongside livestock manure and
aquaculture (Sarmah, Meyer, et al., 2006b; Kolodziej, Harter, & Sedlak,
2004). In fact, several studies have shown that a considerable fraction of
the polar metabolites of E2 and EE2 can be cleaved in WWTPs, resulting
in discharge of the initial compounds (Panter, Thompson, Beresford, &
Sumpter, 1999; Ternes et al., 1999; D’Ascenzo et al., 2003). On the other
hand, Temes, Andersen, Gilberg, and Bonerz (2002) stressed that adsorp-
tion to sludge is important role in their removal from wastewaters.
Consequently, the disposal of animal manure, wastewater, and sewage
sludge to agricultural land can lead to the transfer of steroid hormones,
including E2 and EE2, into soils, surface and ground waters (Stumpe &
Marschner, 2007). Another major source of steroid estrogens comes
from the urban environment, mainly from human excretion, being released
into WWT systems in either conjugated or unconjugated forms at micro-
grams per person and day levels (Johnson & Sumpter, 2001; Johnson &
Williams, 2004).
Although the excreted estrogen conjugates are mostly considered to be
biologically inactive, they may be converted back to their parent estrogens
in the environment (Celiz et al., 2009). For instance, Ternes et al. (1999b)
have already reported the deconjugation of 17b-estradiol-17b-D-glucuro-
nide and 17b-estradiol-3b-D-glucuronide in activated sludge slurries, with
increases in E1 and E2 concentrations. Glucuronide metabolite deconjuga-
tion in domestic wastewaters also occurs (D’Ascenzo et al., 2003). b-glucur-
onidase and arylsulfatase enzymes of E. coli (abundant in activated sludge)
can deconjugate glucuronide and sulfate conjugates back to their active
estrogen forms (Ternes et al., 1999; Matejicek, Houserova, & Kuban, 2007).
Investigation of the effect of E2 in soils shows that its mineralization
occurs co-metabolically and is limited by sorption, whereas testosterone
seems to be utilized directly by soil microorganisms (Stumpe & Marschner,
2007). Stumpe and Marschner (2007) found that E2 is more strongly
sorbed into the soil matrix than testosterone. Regarding the biodegradation
of E2 and EE2 in soils, it has been found that, despite their structural simi-
larities, bacteria can cause E2 mineralization whereas EE2 seems to be min-
eralized by white-rot fungi (Stumpe & Marschner, 2009).
Several environmental impacts could be related to exposure to E2 and
EE2 affecting aquatic biota, soils, surface and ground waters (among
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others). Indeed, bodies of water with high estrogen levels, including down-
stream WWTPs effluents, may have a pronounced effect on aquatic species,
leading to fish being feminized (McAvoy, 2008). Estrogens can deregulate
and interfere with normal biological responses by mimicking natural hor-
mones and disrupting signal pathways, like endocrine disrupters. Chronic
exposure of fathead minnows (Pimephales promelas) to low E2 concentra-
tions (5 to 6 ng L1) feminize males through the production of vitellogenin
(VTG) mRNA (evidenced by intersex changes in males), impact on gonadal
development, and altered oogenesis in females (Kidd et al., 2007). EE2 also
had the same effect (Bila & Dezotti, 2007). Moreover, estrogens (including
E2 and EE2) and their mimics can cause severe damage to fish populations,
as shown by the rapid decrease fish stocks in contaminated lakes (Bila &
Dezotti, 2007; Kidd et al., 2007). Furthermore, fish reproductive rate can be
reduced over 3 generations (Cripe et al., 2009), and Bila and Dezotti (2007)
stated that E2 can affect egg production in turtles, as well as inducing
blood VTG content.
Concerning the effect of the chronic exposure to contaminant estrogens
in water and food products on humans, Swan, Liu, Overstreet, Brazil, and
Skakkebaek (2007) found that hormones (used as growth promoters) were
responsible for the reduction of the sperm count in the male offspring of
women with a high red meat regime during gestation. Indeed, a number of
studies have already shown that, over the past 60 years, the average sperm
count in some countries has halved and the incidence of 33 malformations
on the male reproductive system has doubled. Chronic exposure of adult
males to estrogenic substances may result in breast growth and interference
with the hypothalamus, pituitary and gonadal glandular systems, resulting
in decreased libido, impotence, decreased androgen levels in the blood and
decreased sperm count (Auger, Kunstmann, Czyglik, & Jouannet, 1995;
Waring & Harris, 2005). Furthermore, contaminant estrogens, with rele-
vance to EE2, are thought to induce some diseases, such as uterus, breast
and prostate cancer, male fertility reduction, abnormal sexual development,
abnormal thyroid glands, increased polycystic ovaries incidence, disturban-
ces in ovarian functions, fertilization and pregnancy, endometriosis and
neurobehavioral effects (Soto, Justicia, Wray, & Sonnenschein, 1991; Adeel,
Song, Wang, Francis, & Yang, 2017; Verbinnen, Nunes, & Vieira, 2010;
Birnbaum & Fenton, 2003; Coleman, Abdullah, Eggins, & Palmer, 2005;
Solomon & Schettler, 2000; Gray, 1998; Daston et al., 1997). Finally, Sodre,
Locatelli, Montagner, and Jardim (2007) emphasize that the embryonic
stage is much more susceptible to estrogens compared to adults. Indeed,
exposure at early stages of development can change developmental proc-
esses themselves, whereas at a more advanced stage they can solely interfere
with reproduction or affect the offspring (Arcand-Hoy & Benson, 1998).
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3. Impact of PhACs in the microbial communities of WWT systems
The main impacts of SMX, CBZ, E2, and EE2 in the microbial commun-
ities of biological WWT systems are discussed more fully in this section.
A few studies have already been conducted to understand the effect of
SMX in microbial communities of WWTPs. Bacteria belonging to
Betaproteobacteria and Gammaproteobacteria classes seemed to be the
dominant species in WWT systems treating this compound (Cydzik-
Kwiatkowska & Zielinska, 2016). Moreover, the disappearance of species
belonging to the Sphingobacteria, Actinobacteria, Chloroflexi and Chlorobi
classes suggests that these species are strongly affected by SMX in CAS sys-
tems (Collado et al., 2013). Similar results showed that bacteria belonging
to Betaproteobacteria and Gammaproteobacteria were dominant in WWT
systems with antibiotic removal using anoxic/oxic membrane biological
reactor (A/O-MBR) processes. Indeed, monitoring Thiothrix spp.
(Gammaproteobacteria) showed that the number of living cells increased
due to its augmented antibiotic tolerance. However, in a different study
(Novo, Andre, Viana, Nunes, & Manaia, 2013), the SMX concentration and
the abundance of antibiotic resistant cultivable bacteria in raw wastewaters
from full-scale WWTPs were positively correlated with the abundance of
Epsilonproteobacteria in treated wastewater and negatively correlated with
Gammaproteobacteria, Betaproteobacteria and Firmicutes.Guo, Pang, Dou,
and Yin (2017) found that SMX and chemical oxygen demand (COD)
could change the structures of bacterial community within a sequencing
batch reactor (SBR). However, Simpson’s index of diversity and the
Shannon-Weiner index values showed no significant change in bacterial
diversity by these compounds. The sludge retention time (SRT) significantly
influences the relative numbers of nitrifying bacteria (Xia et al. 2012).
These results suggest that SMX may affect removal of nitrogenous com-
pounds from biological systems, reducing the efficiency of ammonia nitro-
gen disposal (Guo et al., 2017). Other data help in elucidating the fact that
denitrification processes are more vulnerable than nitrification and carbon
oxidization processes under SMX stress. Indeed, the relative abundance of
denitrifiers decreased by 86% at a SMX concentration of 2000mg L1 (Zhu
et al., 2017).
Even though there is a significant lack of knowledge regarding the
impact of anticonvulsants on microbial communities, according to
Aubenneau, Tahar, Casellas, and Wisniewski (2010) some effects on both
the respiratory activity of bacterial communities and on the bacterial
agglomerate sizes could be related to CBZ exposure. And although no
apparent inhibition occurs in the presence of 1 mg L1 of CBZ, the oxygen
uptake rate (OUR) increased under endogenous conditions. A possible
explanation lies in an increase in the maintenance requirements as a result
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of CBZ-induced chemical stress. On the other hand, an OUR decrease was
noted under exogenous conditions, which may be attributed to a change in
the microbial community structure or the activity of individual species
(Aubenneau et al., 2010). Cripe et al. (2009) found a negative effect of CBZ
in the activity of the microbial communities of a MBR, leading to an initial
OUR decrease, corresponding to the first CBZ dosing period. However, it
was also noticed that from that moment onwards, the biomass behavior
was quite similar with or without CBZ. Regarding the effect of CBZ in
mixed microbial cultures (MMC) from full-scale WWTPs, growth inhib-
ition was found relevant, being related to the CBZ concentration, especially
under lower organic load conditions (Wang, Holzem, & Gunsch, 2008).
These results suggest that further studies should be encompass the eco-
logical impacts of CBZ in WWTPs with different biological systems.
Due to the persistence of EE2 in the environment, it is necessary to care-
fully identify the microorganisms able to degrade this compound, including
metabolic processes involved (Cajthaml, Kresinova, Svobodova, Sigler, &
Rezanka, 2009). Investigations are under way to better understand the
effect of EE2 on activated sludge bacterial communities, and are showing
that Firmicutes are negatively correlated with EE2 concentrations in a pilot
scale reactor (Kruglova, Gonzalez-Martinez, Matilda Kråkstr€om, Mikola, &
Vahala, 2017). Other studies, conducted to understand the effect on acti-
vated sludge microbial communities caused by EE2 assimilation under both
aerobic and anaerobic conditions showed that microbial diversity decreased
(Wang, Tam, & Zhang, 2011). Furthermore, Proteobacteria were the pre-
dominant class (due to their EE2 biodegradation abilities), including
Pseudomonas thermotolerans, Rhodanobacter lindaniclasticus, Azonexus
caeni and Rhodanobacter sp. (Wang et al., 2011). As a result, EE2 biodeg-
radation efficiencies were reported to be 80% under both aerobic and
anaerobic conditions.
Regarding the biodegradation ability of E2 and its effects on the micro-
bial communities in WWT systems, Pholcan, Baptista, Davenport, Sloan,
and Curtis (2013) showed that decreasing microbial diversity was associated
with a decline in E2 removal.
Given the lack of further significant published research on the impact of
sulfonamides (and other antibiotics), anticonvulsants, and steroid estrogens
in the microbial communities of WWT systems, and particularly of full-scale
systems, additional studies are needed on these points of major interest.
4. PhACs removal in biological WWT systems
The increasing concern about the environmental and human health risks of
PhACs led to the development of several removal technologies for these
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compounds, ranging from CAS, MBR and moving bed biofilm reactor
(MBBR) systems to fungal and enzymatic treatments, among others (Badia-
Fabregat, Oller, & Malato, 2017).
Among the most widely used, CAS and MBR systems have been 2 of the
major options. In fact, MBR systems, which include biological degradation
of organic matter coupled with membrane filtration, emerged during the
last few years as a promising technology that surpass some of the limita-
tions of the CAS treatment systems, such as limited SRT operational con-
trol and sludge settling (Radjenovic et al., 2009). Taking this into
consideration, the influence of operational and chemical parameters in CAS
and MBR systems for PhACs removal will be addressed in the next section.
Knowledge of the PhACs key physicochemical properties seem to be rele-
vant to the assessment of their removal efficiency in WWT systems
(Stevens-Garmon, Drewes, Khan, McDonald, & Dickenson, 2011; Hyland,
Dickenson, Drewes, & Higgins, 2012). Therefore, the most relevant physi-
cochemical properties in this respect, including the water solubility and
Log octanol-water coefficient (Log Kow) values for CBZ, SMX, E2 and
EE2, are shown in the supplementary information (Tables 1–3). The Log
Kow value has proved useful as a means of predicting biodegradation and
sorption behavior (moderate sorption potential for organic compounds
with Log Kow values between 2.5 and 4, and higher potential for values
>4), for a number of different compounds (Martın, Camacho-Mu~noz,
Santos, Aparicio, & Alonso, 2012; Rogers, 1996).
PhACs removal from wastewaters is receiving more attention over the
last few years mainly due to their large environmental impact in surface
waters, aquatic biota and soils, due to their inefficient removal by trad-
itional biological WWT systems. Several technologies have been used to
remove PhACs, including CAS, MBR and EMR systems, hybrid technolo-
gies (involving a number of different systems, such as biofilms and sus-
pended biomass), and treatment with the Trametes versicolor fungi, among
others. Taking this into consideration, the main biological WWT technolo-
gies used for sulfonamides, anticonvulsants and steroid estrogens removal,
both in pilot-scale reactors and full-scale plants, will be described below.
4.1. Full-scale WWTPs
A significant number of studies have tried to determine the removal effi-
ciencies of PhACs on full-scale WWTPs. A literature survey of the main
works encompassing SMX, CBZ, E2 and EE2 removal efficiencies in full-
scale WWTPs is presented in Table 3.
Elimination of SMX has been investigated in full-scale WWTP with dif-
ferent biological WWT systems by G€obel, Thomsen, McArdell, Joss, and
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Giger (2005, G€obel, McArdell, Joss, Siegrist, & Giger, 2007) and Polesel
et al. (2016) among others. Removal of SMX in full-scale WWTPs occurs
mainly by biotransformation, though deconjugation of metabolites back to
the parent form can have a negative effect on the removal efficiency
(Polesel et al., 2016). In this sense, the most commonly studied conjugated
metabolite of SMX in full-scale WWTPs is N4-acetyl-SMX (G€obel et al.,
2007), and the sorption of this metabolite can be considered negligible due
to its chemical properties (Polesel et al., 2016).
CBZ remains recalcitrant in full-scale WWTPs due to its high solubility
and low distribution coefficient between wastewater and sludge (Kruglova
et al., 2014; Odize et al., 2017; Clara et al., 2005). Moreover, similar results
showing slight or no removal were obtained for CBZ and 5 of its metabo-
lites (10,11-dihydro-10,11-dihydroxy-CBZ, 10,11-dihydro-10-hydroxy-CBZ,
10,11-epoxy-10,11-dihydro-CBZ, 2-hydroxy-CBZ and 3-hydroxy-CBZ) in
German and Portuguese full-scale WWTPs (Bahlmann et al., 2014). On the
other hand, full-scale constructed wetlands (CW) were useful for CBZ and
SMX removal purposes (Gross, Montgomery-Brown, Naumann, &
Reinhard, 2004; Matamoros, Garcıa, & Bayona, 2008; Hijosa-Valsero,
Matamoros, Martın-Villacorta, Becares, & Bayona, 2010; Anderson et al.,
2013; Lee, Lee, Park, Kim, & Cho, 2013). Nevertheless, conflicting results
have been reported by these authors, ranging from no effective removal of
both compounds in a study conducted in Canada (Anderson et al., 2013),
from 15 to 37% CBZ removal efficiencies in full-scale and surface flow CW
reported in Spain (Hijosa-Valsero et al., 2010).
With respect to estrogens, removal efficiencies of >90% for E2 and EE2
in municipal WWTPs were obtained under both aerobic and anaerobic
conditions (Joss, Andersen, Ternes, Richle, & Siegrist, 2004). However,
whereas E2 was oxidized and further eliminated by a CAS system in a
WWTP in Germany, EE2 remained mainly persistent according to Ternes
et al. (1999). In addition, investigations evaluating different full-scale
WWTPs technologies were crucial for a deeper understanding of the
removal process of estrogens. Braga et al. (2005) found that the removal
efficiencies of estrogens were higher in WWTPs with microfiltration (MF),
reverse osmosis (RO) and chlorination/dichlorination compared to the
WWTP with FeCl3 addition. Taking into account the relatively low solids
concentration in the enhanced primary treatment, the degree of estrogens
partitioning in the organic fraction was thought to be responsible for the
difference between the 2 plants. Miege et al., 2009 reported greater removal
efficiencies for steroid estrogens in AS systems with nitrogen removal and
membrane bioreactors. In addition, EE2 removal in fixed biomass reactors
and waste stabilization ponds occurred predominantly in the liquid phase,
under high solids retention time (SRT) conditions. Johnson et al. (2005)
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compared the concentration of steroid estrogens (E1, E2 and EE2) in
treated effluents from different WWTPs presenting diverse WWT technolo-
gies, finding that the lowest estrogen removals occurred in the WWTP
with solely a primary chemical treatment, whereas higher efficiencies were
seen in WWTPs with AS and oxidation ditch (OD) systems.
With the purpose of understanding the behavior and the removal effi-
ciencies of estrogens in a full-scale WWTP in Australia, Ying, Kookana,
and Kumar (2008) showed that the removal rates of estrogens were consist-
ent with the biochemical oxygen demand (BOD), mixed liquor suspended
solids (MLSS) and ammonia removal efficiencies. Higher BOD, MLSS and
ammonia values resulted in lower removal efficiencies of estrogens.
Moreover, this study pointed out that the least efficient studied WWTP
consisted of a series of anaerobic and aerobic lagoons whereas the most
efficient was in CAS and OD systems.
4.2. Influence of operational and chemical parameters
in CAS and MBR systems
As previously mentioned, the sustainable removal of PhACs from waste-
waters is nowadays of major interest, and an increasing number of reports
relating to the operational conditions and their removal efficiencies. To this
effect, the main studies encompassing SMX, CBZ, E2 and EE2 removal effi-
ciencies in AS and MBR systems under different operation conditions are
presented in Table 4.
Keeping the above in mind, and with respect to sulfonamides, SMX is
only partially removed in the primary treatment of WWTPs (Perez,
Eichhorn, & Aga, 2005). On the other hand, Xia et al. (2012) showed that
high SRT (>30 days) in the secondary treatment (using anoxic/aerobic
membrane bioreactors – A/O-MBR) gave removal efficiencies >80% for a
number of antibiotics, including SMX. Nevertheless, comparable removal
efficiency results have been obtained using an MBR operated with 15 to
30 days of SRT (Kimura, Hara, & Watanabe, 2007; Tambosi et al., 2010),
suggesting that the removal efficiency is not strictly related to this oper-
ational parameter. Given the dependency of SMX removal efficiencies
under the SRT conditions, other reports were on the use of 2 MBR systems
at different SRT (15 and 30 days), with SMX removal efficiencies of,
respectively, 55 and 64% (Tambosi et al., 2010; Schr€oder et al., 2012).
However, Suarez et al. (2010) showed that SMX degradation was independ-
ent of DO levels.
Regarding CAS systems, Yang et al. (2012) found that SMX was completely
removed within 13 h. However, comparing the SMX removal in CAS and MBR
systems, others have shown diverse SMX removal efficiencies. Indeed, MBR
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was for the most part more efficient for SMX removal than CAS systems
(Radjenovic, Petrovic, and Barcelo, 2007; Radjenovic et al., 2009).
A number of studies focusing on the use of CAS and MBR systems to
remove CBZ have has given conflictive or even opposite results
(Grandclement et al., 2017); these conflicting results are probably due to
differences in the operating conditions of the CAS systems being compared,
such as the SRT, hydraulic retention time (HRT) or MLSS, but also to the
sludge and the wastewaters chemical composition (Grandclement et al.,
2017). A number of other investigations have shown that CAS systems are
largely inefficient for the removal of CBZ due to the deconjugation (during
the WWT) of conjugates by hydrolysis, which could lead to an increase of
the contaminant load. Indeed, the CBZ removal inefficiency is well known
to be related to its chemical properties (Mohapatra et al., 2014).
Contrary to SMX, studies on the relationship between the operational
conditions in a MBR reactor and CBZ removal efficiencies showed that this
compound remains recalcitrant regardless of the SRT values (Bernhard,
M€uller, & Knepper, 2006; Maeng, Choi, Lee, & Song, 2013). Furthermore,
and regarding the influence of the HRT (Gros, Petrovic, Ginebreda, &
Barcelo, 2010) and pH (Tadkaew, Sivakumar, Khan, McDonald, & Nghiem,
2010), the CBZ removal efficiency also did not show any clear relationship
between these parameters. Several other studies have compared removal
efficiencies of several PhACs by CAS and MBR systems, including CBZ.
According to Bernhard et al., (2006), MBR had higher removal efficiencies
than CAS regarding a number of polar contaminants, whereas recalcitrant
compounds, e.g. CBZ, were not eliminated.
Regarding the removal and biodegradation efficiencies of estrogens,
reports include both pilot-scale reactors and full-scale plants; as a result,
crucial knowledge about these compounds structures, their transformation
pathways, and the relation between removal efficiencies and operational
conditions has emerged (Cajthaml et al., 2009; Liu et al., 2015; Ting &
Praveena, 2017). Regarding the temperature effect on the removal efficien-
cies of estrogens, a higher efficiency is found in summer (average 26.4 C)
than in winter (average 16.4 C) (Nakada et al., 2006). However, Suarez
et al. (2012) found higher removal efficiencies of EE2 in CAS systems in
the temperature at 10–35 C than above 45 C.
Iit is well known that estrogens (e.g. E2 and EE2) removal can also be
affected by other conditions, including SRT and HRT values and MLSS con-
tents. Indeed, high SRT (especially from 20 to 24days) leads to higher efficien-
cies of the removal on estrogens (Clara, Kreuzinger, Strenn, Gans, & Kroiss,
2005; Carballa, Omil, Ternes, & Lema, 2007; McAdam et al., 2010; Petrie,
McAdam, Hassard, Stephenson, Lester, & Cartmell, 2014). With respect to the
MLSS influence, there have been contradictory results; while Suzuki and
720 C. S. LEAL ET AL.
Maruyama, (2006) reported no differences in removal efficiencies in CAS sys-
tems, varying the MLSS from 1619mg L1 to 1921mg L1, Chen and Hu
(2009) and Li, Yuasa, Obara, and Mathews, (2005) showed increased efficiency
in batch tests by varying the MLSS from 4 g L1 to 12.5 g L1, and from
435mg L1 to 1750mg L1, respectively. Suarez et al. (2010) showed that
removal efficiencies of 99% for E2and 87% for EE2 with regard to the influence
of HRT could be obtained with a 24h HRT (for a MLVSS of 1.6 g L1 and a
temperature range from 16 to 20 C) in CAS systems. These results suggest that
other factors besides temperature, HRT, SRT and MLSS, e.g. the initial estro-
gens concentration, could play a major role in their removal processes. In fact,
other operational conditions were found relevant in improving the biodegrad-
ation kinetics of EE2 in CAS processes, including the food to microorganism
ratio (F/M). Ziels, Lust, Gough, Strand, and Stensel (2014) indicated that popu-
lation selection, in low organic substrate concentrations, can improve EE2 bio-
degradation kinetics. Maeng et al. (2013) obtained better removal efficiencies
for E2 than EE2 in MBR systems when nitrification was inhibited. In this sense,
more work is needed to clarify the influence of the above parameters in E2 and
EE2 removal efficiencies in WWTPs.
Although Hashimoto and Murakami (2009) showed that estrogens can be
completely removed after 24 h in batch experiments using samples from CAS
and OD full-scale WWTPs, Kim, Cho, Kim, Vanderford, and Snyder (2007)
results suggest that MBR could be more efficient in hormones (estriol, testos-
terone, androstenedione) removal from wastewaters than CAS systems.
In comparing PhACs removal efficiencies between the CAS and MBR
systems favoring the latter, it should be emphasized that these results could
be partially explained by the differences in the operational conditions (e.g.
SRT). Nonetheless, it is also known that the floc surface, per reactor vol-
ume, is 10 times higher in MBR than in CAS, suggesting that the contact
between microorganisms and pollutants could be favored in MBR, thus
stimulating enzymatic activity (Cirja, Ivashechkin, Sch€affer, & Corvini,
2008). However, it should be noted that natural and human originated
metabolites and PhACs by-products can be even more toxic than the par-
ent compounds, such as chlorine by-products in disinfection (Buttiglieri &
Knepper, 2008).
4.3. Fungi treatments, EMR and HS
In the last few years, a number of different WWT methodologies, e.g. fungi
treatments, EMR and HS, have been examined regarding the removal of
PhACs from wastewaters. To this effect, the major reports encompassing
SMX, CBZ, E2 and EE2 removal efficiencies using these systems are pre-
sented in Table 5. Rodarte-Morales, Feijoo, Moreira, and Lema (2011)
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focusing on the removal of SMX using white rot fungi, found complete deg-
radation after 14 days of incubation with the 3 fungal strains (an anamorph
species of Bjerkandera sp. R1, Bjerkandera adusta and Phanerochaete chryso-
sporium). Fungi were also of interest in the degradation of estrogens (E2 and
EE2), including the use of laccase from T. versicolor (Auriol, Filali-Meknassi,
Tyagi, & Adams, 2007) and other enzymatic solutions. In fact, MnP solutions
produced by P. ostreatus gave an 80% EE2 removal efficiency (Cajthaml
et al., 2009; Suzuki, Hirai, Murata, & Nishida, 2003). Others showed that
enzymatic reactions mediated by vanillin, p-coumaric acid or ferulic acid
achieved EE2 removal percentages ranging from 80 to 100% after 24 h
(Nguyen, Hai, Kang, Price, & Nghiem, 2013).
Significant research has also been developed to achieve CBZ removal
using fungi treatments. One of the most employed organisms in CBZ
removal from aqueous media is T. versicolor; Jelic et al. (2012) reported a
high removal efficiency (96%) using an air-pulsed fluidized bed bioreactor
operated under batch conditions. On the contrary, Cruz-Morato et al.
(2013) found that the deconjugation of CBZ intermediates led to
increased CBZ in a fluidized bed bioreactor treating real wastewater with
T. versicolor. Others have also exploited the potential of commercial fungi
(e.g. T. versicolor) based enzymes; Tran, Urase, and Kusakabe (2010)
reported CBZ removal efficiencies just under 40% with commercial lac-
case. Phanerochaete chrysosporium fungi has also been used to evaluate in
vitro degradation of CBZ. Zhang and Geissen (2010) batch experiments
yielded poor (mostly <10%) to no CBZ removal abilities using P. chryso-
sporium lignin peroxidase (LiP). On the contrary, the use of manganese
peroxidase (MnP) solutions produced by Pleurotus ostreatus degraded
98% of CBZ (Zhang & Geissen, 2010; Golan-Rozen, Chefetz, Ben-Ari,
Geva, & Hadar, 2011).
However, there have been conflicting results regarding a wider range of
PhACs removal strategies. Thus, the interest in studying HS by combining
one or more treatment processes for this purpose has been increasing.
Tang et al. (2017) found poor removal SMX efficiencies (10%) and CBZ
recalcitrance in a polishing MBBR. In fact, poor removal CBZ efficiencies
had been reported beforehand in a hybrid biofilm-activated sludge process
and in a MBBR (Falås et al., 2013; Luo et al., 2014). On the contrary, 80%
of CBZ removal was obtained in an integrated fixed-film activated sludge
membrane bioreactor (IFAS-MBR) (De La Torre et al., 2015). In another
study, a hybrid biofilm and activated sludge system (HybasTM) has been
used for hospital wastewater (containing SMX and CBZ) treatment, obtain-
ing 30% in removal efficiency for both compounds (Escola Casas et al.
2015). Regarding steroid estrogens removal in hybrid systems, De la Torre
et al. (2015) achieved complete (100%) E2 and EE2 removal in an IFAS-
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MBR, whereas removal efficiencies >80% were obtained by Luo et al.
(2014) using a sponge-based MBBR.
5. Concluding remarks and future perspectives
PhACs, including sulfonamides, anticonvulsants and estrogens, are widely
present in municipal sewage, largely due to human excretion, causing ser-
ious environmental damage. Although a number of different biological
WWT systems can be found in WWTPs, AS and MBR systems remain the
most widely operated. However, these systems have shown - for the most
part - inefficiency in the removal of these compounds, with serious conse-
quences to aquatic life and human health. With this in mind, concern over
the development of new sustainable removal technologies is increasing,
including EMR, fungi treatments and HS. Therefore, the main commonly
employed biological WWT systems for PhACs removal, particularly sulfo-
namides (SMX), anticonvulsionants (CBZ) and steroid estrogens (E2 and
EE2) are being addressed, as well as their main environmental impacts,
mainly in terms of aquatic biota, soil and human health.
Although AS systems (including CAS, SBR, OD and other configura-
tions) are frequently inefficient in the removal of PhACs (including CBZ,
SMX, E2, and EE2), a number of different investigations focusing on the
removal efficiencies of these systems have been published. In fact, several
factors have been thoroughly studied, including different PhAC concentra-
tions, system configurations, and diverse chemical and operational condi-
tions. Furthermore, it has also been found that MBR systems are more
suitable and efficient than CAS systems. That being the case, more research
is required to enlighten and corroborate these previous findings.
Despite the undertaken efforts regarding CAS and MBR systems, it
should be pointed out that some PhACs, e.g. CBZ, remain recalcitrant in
these systems; thus, the development of EMR, fungi treatments and HS
removal methodologies is a major focus of interest. Again, a number of dif-
ferent strategies for the removal of SMX, CBZ, E2 and EE2 for such tech-
nologies have been published, although with varying removal efficiencies
being reported.
The evaluation of the above technologies in terms of cost-benefit should
also be exploited to achieve sustainable implementation in full-scale
WWTPs. In this sense, future studies encompassing the use of alternative
technologies (e.g. aerobic granular sludge) for PhACs removal are needed.
Further investigation should also address the problem of improving the
ability of these technologies to achieve sustainable removal of PhACs, and
to understand the relationships between the operational parameters and
correspondent removal efficiencies. Moreover, long-term exposure
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(chronic) effects of products resulting from PhACs degradation should be
also investigated in future studies.
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